For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he's one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal ...
Aug 24, 2021
0
43
The United States recently secured 1.7 million doses of a compound that could help to treat COVID-19 patients. In preliminary studies, Molnupiravir reduced the transmission of the SARS-CoV-2 coronavirus. Researchers at the ...
Aug 16, 2021
0
1070
The coronavirus that causes COVID-19 has demonstrated a stubborn ability to resist most nucleoside antiviral treatments, but a new study led by an Iowa State University scientist could help to overcome the virus's defenses.
Aug 3, 2021
0
920
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind. But HIV's ability to mutate isn't unique among RNA viruses—most viruses ...
Jul 2, 2021
0
149
Researchers from the Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the LIH Department of Oncology (DONC) are working on the development of novel anticancer strategies based on oncolytic viruses, 'good' viruses ...
Jun 29, 2021
0
22
Researchers at Karolinska Institutet in Sweden have developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants. The technique is presented in the scientific journal Nature Communications.
Jun 23, 2021
0
12
A team of scientists headed by SANKEN (The Institute of Scientific and Industrial Research) at Osaka University demonstrated that single virus particles passing through a nanopore could be accurately identified using machine ...
Jun 17, 2021
0
4
Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research Group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in ...
Jun 7, 2021
0
5
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health. TEMPOL can limit SARS-CoV-2 infection by impairing ...
Jun 3, 2021
0
20
DEAR MAYO CLINIC: I know COVID-19 has been around now for over a year, but I'm still confused by the different types of vaccines, including messenger RNA and vector vaccines. Can you explain how these vaccines work and the ...
Jun 1, 2021
0
4
